Who
Ann Calby Miller
Director
Company insider
Files Form 4 as: Director, Inovio Pharmaceuticals; Director, Puma Biotechnology; Director, Allena Pharmaceuticals.
In numbers
- Trades disclosed
- 42
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $147K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 21 Mar 2019
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,800 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,200 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,800 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,200 at $0.00 | filing |
| 21 May 2025filed 21 May 2025 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,167 at $0.00 | filing |
| 21 May 2025filed 21 May 2025 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,167 | filing |
| 21 May 2024filed 22 May 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,917 at $0.00 | filing |
| 21 May 2024filed 22 May 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,167 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,166 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,166 | filing |
| 16 May 2023filed 16 May 2023 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —19,000 at $0.00 | filing |
| 16 May 2023filed 16 May 2023 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —19,000 | filing |
| 15 May 2023filed 16 May 2023 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 15 May 2023filed 16 May 2023 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 16 May 2022filed 17 May 2022 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 16 May 2022filed 17 May 2022 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 13 May 2022filed 17 May 2022 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,000 at $0.00 | filing |
| 13 May 2022filed 17 May 2022 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —18,000 | filing |
| 21 Mar 2022filed 22 Mar 2022 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,273 at $0.00 | filing |
| 21 Mar 2022filed 22 Mar 2022 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,273 | filing |
News
Head to Head Contrast: Aurinia Pharmaceuticals (NASDAQ:AUPH) & Puma Biotechnology (NASDAQ:PBYI)PBYI · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Ann Calby Miller; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.